TCL Archive FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+. June 2, 2000
TCL Archive Prevention Facility For Intramural Research Approved, Also Would Involve Academic Investigators November 1, 1991
TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
